Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population

Primer Autor
Cerda, Alvaro
Co-autores
Manriquez, Victor#Aviles, Jorge#Salazar, Luis#Saavedra, Nicolas#Seron, Pamela#Lanas, Fernando#Fajardo, Cristina Moreno#Hirata, Mario Hiroyuki#Crespo Hirata, Rosario Dominguez
Título
Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population
Editorial
ADIS INT LTD
Revista
MOLECULAR DIAGNOSIS & THERAPY
Lenguaje
en
Resumen
Background Polymorphisms in genes encoding proteins of the leptin-melanocortin pathway have been associated with obesity. The involvement of these polymorphisms with changes in body mass index (BMI) and anthropometric measures could also imply a contribution to the risk of metabolic syndrome (MetS) and metabolic alterations. We evaluated the relationship of leptin-melanocortin system polymorphisms with obesity, MetS, and other metabolic alterations in Southern Chilean individuals. Methods Two-hundred individuals were grouped as normoweight (BMI 18.0-24.9 kg/m(2)), overweight (BMI 25.0-29.9 kg/m(2)), and obese (BMI C 30 kg/m(2)) or according to MetS status. Anthropometric measures (BMI, abdominal circumference, waist-to-hip ratio [WHR]) and biochemical parameters (glycemia and lipid profile) were evaluated. Polymorphisms LEP rs7799039, LEPR rs1137101, MC3R rs3746619 and rs3827103, and MC4R rs17782313 were evaluated by real-time PCR using allelic discrimination assays. Results LEPR rs1137101 GG genotype was related to reduced risk of obesity (odds ratio [OR] 0.26, 95% confidence interval [CI] 0.08-0.79, p = 0.018) and MetS (OR 0.36, 95% CI 0.15-0.88, p = 0.024), but it was not significant after Bonferroni correction for multiple tests as compared to the AA genotype (p[0.01). Moreover, LEPR rs1137101 allele G (AG + GG) was related to lower BMI and WHR (p < 0.01). Further multiple linear regression analysis demonstrated that this genotype was also responsible for reduced BMI in 2.44 kg/m(2) and WHR in 0.033 units. MC4R rs17782313 allele C (TC + CC) was slightly associated with diminished risk of MetS (OR 0.48, 95% CI 0.23-0.98, p = 0.040) and reduced BMI values in 1.95 kg/m(2) (p < 0.05). Regarding lipid profile, LEPR rs1137101 allele G carriers had lower triglycerides and very-lowdensity lipoprotein (VLDL) cholesterol, whereas individuals carrying the MC4R rs17782313 allele C had higher high-density lipoprotein (HDL) cholesterol (p < 0.01). LEP rs7799039 allele A (GA + AA) was slightly associated with reduced total and low-density lipoprotein (LDL) cholesterol (p < 0.05). Conclusions These results suggest that polymorphisms at LEP, LEPR, and MC4R may be useful biomarkers of obesity-related population.
Tipo de Recurso
Artículo original
Description
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO # DI15-0017), and CNPq- Brazil (# 462778/2014-2).
Esta investigación fue apoyada por subvenciones de FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO
DI15-0017) y CNPq-Brasil (
462778/2014-2).
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO
DI15-0017), and CNPq- Brazil (
doi
10.1007/s40291-017-0306-8
Formato Recurso
pdf
Ubicación del archivo
http://dx.doi.org/10.1007/s40291-017-0306-8
Categoría OCDE
Genetics & Heredity# Pharmacology & Pharmacy
Disciplinas de la OCDE
Genética y Herencia
Fisiología
Endocrinología y Metabolismo (Incluye Diabetes, Hormonas)
Id de Web of Science
WOS:000422910300008
Título de la cita (Recomendado-único)
Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population
Identificador del recurso (Mandatado-único)
Artículo original
Versión del recurso (Recomendado-único)
version publicada
Editorial
ADIS INT LTD
Revista/Libro
MOLECULAR DIAGNOSIS & THERAPY
Categoría WOS
Genética y Herencia# Farmacología y farmacia
ISSN
1177-1062
Idioma
en
Referencia del Financiador (Mandatado si es aplicable-repetible)
ANID FONDECYT 11150445#UFRO DI15-0017#CNPq 462778/2014-2
ANID FONDECYT 11150445
URO DI15-0017
CNPq 462778/2014-2
Descripción
This investigation was supported by grants from FONDECYT-Chile (No 11150445), Universidad de La Frontera-Chile (DIUFRO # DI15-0017), and CNPq- Brazil (# 462778/2014-2).
Formato
pdf
Tipo de ruta
hibrida#verde
Access Rights
metadata
Derechos de acceso
metadata
Página de inicio (Recomendado-único)
1631
Página final (Recomendado-único)
1632
Revisa las metricas alternativas de Almetrics
Revisa las citaciones de Dimensions